LATAM Daily Brief: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on LATAM Daily Brief.

Press releases published on September 24, 2026

17 hours ago

Dynacor Advances Expansion Projects, Ecuador Plant Rehabilitation 65% Complete

Indeterminate GlobeNewswire

17 hours ago

Dynacor poursuit ses projets d’expansion, la réfection de l’usine en Équateur est achevée à 65 %

Indeterminate GlobeNewswire

17 hours ago

DEEP SEA MINERALS CORP. WELCOMES U.S. DEPARTMENT OF THE INTERIOR COMMENTS ON DEEP SEA MINERAL PERMITTING

Indeterminate GlobeNewswire

17 hours ago

Medicenna Announces Oral Presentation of New Bizaxofusp Results in Recurrent Glioblastoma at the 2026 Society for Neuro-Oncology Annual Meeting

Indeterminate GlobeNewswire

17 hours ago

Vistagen Reports Positive Findings Supporting Fasedienol’s Potential in Very Severe Social Anxiety Disorder

Indeterminate GlobeNewswire

17 hours ago

Ligand and AvenCell Therapeutics Enter Financing Agreement to Advance Pipeline of Next-Generation CAR-T Therapies for Up to $47 Million

Indeterminate GlobeNewswire

17 hours ago

GoldInxs Advances Fishpot Toward Maiden Drill Program with New 3D IP Survey, Magnetic and Virtual DRILL™ Results

Indeterminate GlobeNewswire

17 hours ago

Mesoblast Receives FDA Approval for New Potency Assay to Release Commercial Ryoncil Product

Indeterminate GlobeNewswire

18 hours ago

GoldHaven Intersects New Skarn Zone at Kuhn; Drilling Underway from Second Pad

Indeterminate GlobeNewswire

18 hours ago

Kyverna Therapeutics Reports Positive One-Year Data Demonstrating Durable Clinical Responses and Favorable Safety Profile for Miv-cel in Stiff Person Syndrome and Generalized Myasthenia Gravis

Indeterminate GlobeNewswire

Sep. 24, 2026

Fortuna CEO to present at Mining Forum Americas 2026

Indeterminate GlobeNewswire

Sep. 24, 2026

Kasvu Therapeutics Raises €30 Million Series A Financing Round led by Hadean Ventures to Advance its Novel TrkB Potentiator into Clinical Development Targeting Neuropsychiatric Disorders

Indeterminate GlobeNewswire

Sep. 24, 2026

VR Submits NOI Permit Amendment to Expand Drill Sites for its New Boston Moly-Tungsten-Copper-Silver Porphyry Project in Nevada

Indeterminate GlobeNewswire

Sep. 24, 2026

BOOST Pharma Selected to Showcase Phase III Ready Lead Program BT-101 at the 2026 Cell & Gene Meeting on the Mesa

Indeterminate GlobeNewswire

Sep. 24, 2026

Greenland Mines Completes $12-Per-Share Equity Financing, Fully Funded Through 2027 Milestones with $42 Million, Terminates ATM, and Completes Sarfartoq Rare Earth Field Program

Indeterminate GlobeNewswire

Sep. 24, 2026

GeoPark Limited Announces Receipt of Requisite Consents for Its 8.750% Senior Notes Due 2030

Indeterminate GlobeNewswire

Sep. 24, 2026

HUTCHMED Highlights Clinical Data to be Presented at the ESMO Congress 2026

Indeterminate GlobeNewswire